VRTX
Vertex Pharmaceuticals Inc
Price:  
513.26 
USD
Volume:  
638,059.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Vertex Stock Forecast & Price Target

Vertex Stock Price Forecast

The average stock forecast for Vertex Pharmaceuticals Inc (VRTX) in the next 12 months is 574.51 USD. This price target corresponds to an upside of 2.97%. The range of stock forecasts for Vertex is 353.50 - 705.60 USD. Based on the ratings of 36 analysts, the consensus recommendation for Vertex is BUY.
Target Low Average Median High
Price (USD) 353.50 574.51 581.40 705.60
Upside -36.64% 2.97% 4.20% 26.46%

Recommendation Trends

The latest consensus rating for Vertex is "BUY". This is the average recommendation of 36 analysts: 1 strong sell, 0 sell, 6 hold, 18 buy, 11 strong buy. In the previous period, 37 analysts also majorly recommmended "BUY" for Vertex.

Vertex Financial Stock Forecast

Revenue This Year
13.49B
12.39%
from 12.00B
Revenue Next Year
14.89B
10.39%
from 13.49B
EPS This Year
19.03
22.21%
from 15.58
EPS Next Year
21.59
13.40%
from 19.03